Safety Study of CC312 in Adult Patients With Relapsed/Refractory CD19 Positive B-cell Hematologic Malignancies
NCT06037018
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
44
Enrollment
INDUSTRY
Sponsor class
Conditions
Non-hodgkin Lymphoma
Acute Lymphoblastic Leukaemia
Chronic Lymphocytic Leukemia
Interventions
BIOLOGICAL:
CC312
Sponsor
CytoCares Inc